Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5934227 | The American Journal of Pathology | 2011 | 11 Pages |
Abstract
Fibrosis results from inflammatory tissue damage and impaired regeneration. In the context of bleomycin-induced pulmonary fibrosis, we demonstrated that the matricellular protein termed secreted protein acidic and rich in cysteine (SPARC) distinctly regulates inflammation and collagen deposition, depending on its cellular origin. Reciprocal Sparcâ/â and wild-type (WT) bone marrow chimeras revealed that SPARC expression in host fibroblasts is required and sufficient to induce collagen fibrosis in a proper inflammatory environment. Accordingly, Sparcâ/â >WT chimeras showed exacerbated inflammation and fibrosis due to the inability of Sparcâ/â macrophages to down-regulate tumor necrosis factor production because of impaired responses to tumor growth factor-β. Hence, the use of bone marrow cells expressing a dominant-negative form of tumor growth factor-β receptor type II under the monocyte-specific CD68 promoter, as a decoy, phenocopied Sparcâ/â donor chimeras. Our results point to an unexpected dual role of SPARC in oppositely influencing the outcome of fibrosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sabina Sangaletti, Claudio Tripodo, Barbara Cappetti, Patrizia Casalini, Claudia Chiodoni, Silvia Piconese, Alessandra Santangelo, Mariella Parenza, Ivano Arioli, Silvia Miotti, Mario P. Colombo,